CIK 0000711377 · Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 382367843
- Phone
- 5173729200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-19 | Moylan John Patrick Chief Accounting Officer | Shares withheld for taxes | −2,365 | $11.87 | $28K | 29,331 |
| 2026-08-19 | Nassif Mikheal CEO | Shares withheld for taxes | −20,397 | $11.87 | $242K | 25,655 |
| 2026-08-14 | Moylan John Patrick Chief Accounting Officer | Grant or award | +8,584 | $11.65 | $100K | 32,155 |
| 2026-08-14 | Moylan John Patrick Chief Accounting Officer | Grant or award · Common Stock (Right to Buy) | +18,693 | 18,693 | ||
| 2026-08-14 | Ranalli Tamara A. Senior Vice President | Grant or award | +25,751 | $11.65 | $300K | 25,751 |
| 2026-08-14 | Ranalli Tamara A. Senior Vice President | Grant or award · Common Stock (Right to Buy) | +130,851 | 130,851 | ||
| 2026-08-14 | Stacey Jennifer Evans Chief Legal Officer | Grant or award | +38,627 | $11.65 | $450K | 38,627 |
| 2026-08-14 | Stacey Jennifer Evans Chief Legal Officer | Grant or award · Common Stock (Right to Buy) | +196,276 | 196,276 | ||
| 2026-08-14 | Riggsbee Richard Bryan CFO | Grant or award | +51,502 | $11.65 | $600K | 51,502 |
| 2026-08-14 | Riggsbee Richard Bryan CFO | Grant or award · Common Stock (Right to Buy) | +261,702 | 261,702 | ||
| 2026-08-14 | Nassif Mikheal CEO | Grant or award | +141,631 | $11.65 | $1.7M | 141,631 |
| 2026-08-14 | Nassif Mikheal CEO | Grant or award · Common Stock (Right to Buy) | +719,679 | 719,679 | ||
| 2026-08-04 | Nassif Mikheal CEO | Purchase | +370 | $11.81 | $4K | 1,074 |
| 2026-06-03 | Moylan John Patrick Chief Accounting Officer | Shares withheld for taxes | −2,553 | $8.75 | $22K | 23,571 |
| 2026-05-18 | Rocklin Amy M Former Chief Legal Officer | Option exercise | +35,183 | $9.29 | $327K | 92,423 |
| 2026-05-18 | Rocklin Amy M Former Chief Legal Officer | Shares withheld for taxes | −10,241 | $9.29 | $95K | 82,182 |
| 2026-05-18 | Rocklin Amy M Former Chief Legal Officer | Option exercise · Restricted Stock Units | −35,183 | $9.29 | $327K | 0 |
| 2026-05-04 | Moylan John Patrick Chief Accounting Officer | Option exercise | +4,558 | $9.53 | $43K | 18,905 |
| 2026-05-04 | Moylan John Patrick Chief Accounting Officer | Shares withheld for taxes | −1,568 | $9.53 | $15K | 17,337 |
| 2026-05-04 | Moylan John Patrick Chief Accounting Officer | Option exercise · Restricted Stock Units | −4,558 | $9.53 | $43K | 4,558 |
Page 3 of 11 · 210 trades